Violation Tracker Parent Company Summary

Parent Company Name: 
AstraZeneca
Ownership Structure: 
publicly traded (ticker symbol AZN)
Headquartered in: 
Britain
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$1,147,578,284
Number of records: 
21
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$594,000,0004
False Claims Act and related$543,241,15912
consumer protection violation$5,391,0001
kickbacks and bribery$4,325,0001
employment discrimination$600,0002
environmental violation$21,1251
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

ASTRAZENECA; AstraZeneca Pharmaceuticals; AstraZeneca Pharmaceuticals LP; AstraZeneca Pharmaceuticals LP and AstraZeneca LP; MEDIMMUNE DISTRIBUTION

Links: 

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
AstraZeneca LP off-label or unapproved promotion of medical products 2010 FDA $520,000,000
AstraZeneca Pharmaceuticals LP False Claims Act and related 2003 DOJ_CIVIL $354,900,000
AstraZeneca Pharmaceuticals LP off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $218,092,993
AstraZeneca False Claims Act and related 2018 TX-AG $110,000,000
AstraZeneca Pharmaceuticals off-label or unapproved promotion of medical products 2011 MULTI-AG $68,500,000
AstraZeneca LP False Claims Act and related 2015 DOJ_CIVIL $46,500,000
AstraZeneca LP False Claims Act and related 2015 MULTI-AG (*) $46,500,000
AstraZeneca Pharmaceuticals LP False Claims Act and related 2003 MULTI-AG (*) $24,900,000
AstraZeneca False Claims Act and related 2009 KY-AG $14,700,000
AstraZeneca LP False Claims Act and related 2015 DOJ_CIVIL $7,900,000
AstraZeneca off-label or unapproved promotion of medical products 2013 KY-AG $5,500,000
AstraZeneca consumer protection violation 2010 KY-AG $5,391,000
AstraZeneca PLC kickbacks and bribery 2016 SEC $4,325,000
AstraZeneca Pharmaceuticals, LP False Claims Act and related 2010 HI-AG $3,333,333
AstraZeneca Pharmaceuticals False Claims Act and related 2009 DOJ_CIVIL $2,600,000
AstraZeneca Pharmaceuticals LP False Claims Act and related 2009 MULTI-AG (*) $2,600,000
AstraZeneca Pharmaceuticals LP and AstraZeneca LP False Claims Act and related 2011 ID-AG $2,500,000
AstraZeneca False Claims Act and related 2004 FL-AG $807,826
AstraZeneca employment discrimination 2008 private lawsuit-state $350,000
AstraZeneca employment discrimination 2011 OFCCP $250,000
MEDIMMUNE DISTRIBUTION LLC environmental violation 2005 EPA $21,125
Download results as CSV or XML